ADAR1 Capital Management buys InMed Pharmaceuticals shares

ADAR1 Capital Management reported additional purchases of InMed Pharmaceuticals common shares, increasing its holdings to 935,021 shares indirectly through managed private investment funds. Purchases were made at prices of USD 1.3298 and USD 1.33 per share.